Physician profile
Janice Korff
NPI 1962536920
$1,038.81
in general payments reported to CMS, 2019-2025
9 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $115 · 2021: $221 · 2022: $175 · 2023: $142 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270 · Honoraria: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.44 |
| Honoraria | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $310.68 | 2021-2025 | |
| Genentech USA, INC. | $194.22 | 2019-2022 | |
| H2-Pharma, LLC | $150.00 | 2025 | |
| Arbor Pharmaceuticals, INC. | $122.16 | 2019-2021 | |
| Abbott Laboratories | $88.79 | 2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $78.05 | 2023-2025 | Trintellix |
| Paratek Pharmaceuticals, INC. | $49.27 | 2023 | Nuzyra |
| Bausch Health US, LLC | $23.98 | 2021 | |
| Allergan, INC. | $21.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Korff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.